Drug induced interstitial lung disease in oncology phase I trials

Interstitial lung disease is a serious drug‐related condition that can cause life threatening organ failure. The incidence and risk factors of drug‐induced interstitial lung disease (DILD) are unknown in oncology phase I trials. This study analyzed clinical information from 8906 patients with malign...

Descripción completa

Detalles Bibliográficos
Autores principales: Yonemori, Kan, Hirakawa, Akihiro, Kawachi, Asuka, Kinoshita, Fumie, Okuma, Hitomi, Nishikawa, Tadaaki, Tamura, Kenji, Fujiwara, Yasuhiro, Takebe, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198943/
https://www.ncbi.nlm.nih.gov/pubmed/27685762
http://dx.doi.org/10.1111/cas.13087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198943/
https://www.ncbi.nlm.nih.gov/pubmed/27685762
http://dx.doi.org/10.1111/cas.13087

Ejemplares similares